Published in Br J Gen Pract on August 01, 2014
Early Appearance of Principal Symptoms of Kawasaki Disease is a Risk Factor for Intravenous Immunoglobulin Resistance. Pediatr Cardiol (2015) 0.76
Kawasaki disease incidence in children and adolescents: an observational study in primary care. Br J Gen Pract (2016) 0.75
Intravenous immunoglobulin plus corticosteroid to prevent coronary artery abnormalities in Kawasaki disease: a meta-analysis. Heart (2012) 2.41
Kawasaki syndrome: description of two outbreaks in the United States. N Engl J Med (1981) 1.52
Delayed diagnosis of Kawasaki syndrome: an analysis of the problem. Pediatrics (2005) 1.36
Intravenous immunoglobulin for the treatment of Kawasaki disease in children. Cochrane Database Syst Rev (2003) 1.31
Kawasaki disease in England: ethnicity, deprivation, and respiratory pathogens. Pediatr Infect Dis J (2009) 1.18
Genetics of Kawasaki disease: what we know and don't know. Circ J (2012) 1.09
Investigation of Kawasaki syndrome risk factors in Colorado. Pediatr Infect Dis J (2002) 1.02
Kawasaki Disease: A Clinician's Update. Int J Pediatr (2013) 0.93
Understanding the pathogenesis of Kawasaki disease by network and pathway analysis. Comput Math Methods Med (2013) 0.84
[Clinical analysis of 942 cases of Kawasaki disease]. Zhonghua Er Ke Za Zhi (2006) 0.80
Advances in the treatment of Kawasaki disease. Curr Opin Pediatr (2013) 0.80
Kawasaki disease--a diagnostic challenge. Br J Gen Pract (1999) 0.80